CCM
CVS icon

Carderock Capital Management’s CVS Health CVS Stock Holding History

Carderock Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-740
Closed -$63K – 94
2021
Q3 		$63K Buy
+740
New +$62K 0.02% 107
2016
Q4 		– Sell
-24,095
Closed -$2.14M – 79
2016
Q3 		$2.14M Buy
24,095
+244
+1% +$23K 1.07% 44
2016
Q2 		$2.28M Buy
23,851
+28
+0.1% +$2.79K 1.21% 39
2016
Q1 		$2.47M Sell
23,823
-99
-0.4% -$9.63K 1.27% 37
2015
Q4 		$2.34M Buy
23,922
+2,857
+14% +$280K 1.22% 33
2015
Q3 		$2.03M Buy
21,065
+13,114
+165% +$1.38M 1.13% 37
2015
Q2 		$834K Buy
7,951
+3,357
+73% +$343K 0.42% 58
2015
Q1 		$474K Buy
4,594
+184
+4% +$18.6K 0.23% 73
2014
Q4 		$425K Buy
4,410
+110
+3% +$9.69K 0.21% 73
2014
Q3 		$342K Buy
+4,300
New +$339K 0.18% 78
2014
Q2 		– Sell
-1,085
Closed -$81K – 113
2014
Q1 		$81K Buy
+1,085
New +$76.6K 0.04% 121

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carderock Capital Management's CVS Position: Q4 2021 in Review

Carderock Capital Management sold out of CVS Health (CVS) in Q4 2021, closing a stake of 740 shares — an estimated $63K sold.

Carderock Capital Management first reported a position in CVS in Q1 2014 and held it in 11 quarters. The position peaked at $2.47M in Q1 2016. 2,343 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • Carderock Capital Management reported no remaining CVS Health position as of Q4 2021 after selling out during the quarter.
  • Carderock Capital Management sold 740 CVS Health shares in Q4 2021, an estimated $63K.
  • Carderock Capital Management first reported a position in CVS Health in Q1 2014 and held it in 11 quarters.
  • Carderock Capital Management's CVS Health position peaked at $2.47M in Q1 2016.
  • 2,343 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Carderock Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.